Le Centre hospitalier Annecy Genevois est issu de la fusion le 1ᵉʳ janvier 2014 du Centre hospitalier de la Région d'Annecy, implanté à Épagny-Metz-Tessy située au nord d'Annecy en Haute-Savoie, et de l'Hôpital intercommunal Sud Léman - Valserine, implanté à Saint-Julien-en-Genevois, dans le même département.

During the past decade, CH Annecy Genevois conducted 200 clinical trials. In the 10-year time frame, 200 clinical trials started and 14 clinical trials were completed, i.e. on average, 7% percent of trials that started reached the finish line to date. In the past 5 years, 86 clinical trials started and 12 clinical trials were completed. i.e. 14% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Annecy Genevois" #1 sponsor was "The Lymphoma Academic Research Organisation" with 18 trials, followed by "UNICANCER" with 18 trials sponsored, "Centre Hospitalier Annecy Genevois" with 14 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 12 trials sponsored and "University Hospital, Grenoble" with 12 trials sponsored. Other sponsors include 217 different institutions and companies that sponsored additional 104 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Annecy Genevois" #1 collaborator was "Ministry of Health, France" with 13 trials as a collaborator, "University Hospital, Tours" with 8 trials as a collaborator, "University Hospital, Grenoble" with 6 trials as a collaborator, "Hoffmann-La Roche" with 5 trials as a collaborator and "Institut National de la Santé Et de la Recherche Médicale, France" with 5 trials as a collaborator. Other collaborators include 234 different institutions and companies that were collaborators in the rest 206 trials.

According to Clinical.Site data, the most researched conditions in "CH Annecy Genevois" are "Breast Cancer" (13 trials), "Heart Failure" (10 trials), "Multiple Myeloma" (9 trials), "Shock" (6 trials) and "Acute Respiratory Failure" (5 trials). Many other conditions were trialed in "CH Annecy Genevois" in a lesser frequency.

Most popular intervention types in "CH Annecy Genevois" are "Drug" (151 trials), "Other" (57 trials), "Procedure" (30 trials), "Device" (27 trials) and "Biological" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Gemcitabine" (8 trials), "Rituximab" (6 trials), "Doxorubicin" (5 trials) and "Cyclophosphamide" (4 trials). Other intervention names were less common.

The vast majority of trials in "CH Annecy Genevois" are 267 trials for "All" genders, 23 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 88 active trials in "CH Annecy Genevois". 1 are not yet recruiting, 66 are recruiting, 20 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 161 completed trials in CH Annecy Genevois, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in CH Annecy Genevois, 7 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 57 trials that are defined as “Not Applicable".

CH Annecy Genevois has several departments that took part in Clinical trials: "CH Annecy Genevois - Hématologie A3" - 2 trials, "Service de pneumologie; Centre Hospitalier d'Annecy" - 2 trials, "Chra; Gastro Enterologie" - 2 trials